Nathalie Ledee | Medicine and Health Sciences | Innovative Research Award

Published on by Top Teachers

Innovative Research Award

Nathalie Lédée
MatriceLAB Innove, France

Nathalie Lédée
Affiliation MatriceLAB Innove
Country France
Scopus ID 6603321197
Documents 94
Citations 3,407
h-index 33
Subject Area Medicine and Health Sciences
Event Top Teachers Awards
ORCID 0000-0002-3166-2643

Nathalie Lédée, M.D., Ph.D., affiliated with MatriceLAB Innove, France, is a physician-scientist whose work has contributed to the advancement of reproductive medicine, reproductive immunology, embryo implantation biology, and assisted reproductive technologies (ART). Her academic and professional career combines clinical leadership, translational research, biotechnology innovation, and scientific mentorship. She has served in senior research and healthcare leadership positions while maintaining an active publication record and developing patented technologies aimed at improving implantation success and fertility outcomes.[1][2]

Abstract

This article summarizes the academic, clinical, and scientific achievements of Nathalie Lédée, a French physician-scientist specializing in reproductive medicine and reproductive immunology. Her research has focused on understanding immune tolerance, cytokine regulation, embryo implantation mechanisms, and biomarker-guided fertility treatments. Through leadership roles in academia, healthcare institutions, and biotechnology innovation, she has contributed to translational approaches that connect laboratory discoveries with clinical reproductive care. Her scientific output, patents, and international collaborations have influenced contemporary research in embryo implantation and assisted reproduction.[1][3]

Keywords

Reproductive Medicine; Reproductive Immunology; Embryo Implantation; Assisted Reproductive Technology; IVF; Cytokines; Fertility Research; Translational Medicine; Biomarkers; Endometrial Immune Profiling; Clinical Research; Human Reproduction.

Introduction

Nathalie Lédée obtained her Doctor of Medicine degree from the University Paris VI in 1993, completed a Master of Science at McGill University in Canada in 1995, and earned a Ph.D. in reproductive immunology in 2003. Her academic development was complemented by clinical training in obstetrics, gynecology, and reproductive medicine. Throughout her career she has pursued the integration of fundamental immunological discoveries into practical fertility treatments and patient-centered reproductive care.[1]

Her professional activities have included appointments as assistant professor, senior investigator at INSERM research units, invited professor at the University of Liège, head of reproductive medicine centers, and president of MatriceLab Innove. These positions enabled her to contribute to multidisciplinary initiatives linking clinical medicine, biotechnology innovation, and translational research.[2]

Research Profile

Nathalie Lédée’s research centers on the immunological events occurring during embryo implantation and early pregnancy. Her investigations have examined maternal-fetal dialogue, cytokine regulation, immune tolerance, uterine receptivity, and biomarkers associated with reproductive success. She has emphasized translational methodologies designed to improve embryo selection, implantation outcomes, and personalized reproductive therapies.[3]

  • Reproductive Medicine and Fertility Care
  • Reproductive Immunology
  • Embryo Implantation Biology
  • Assisted Reproductive Technologies (ART)
  • Endometrial Immune Profiling
  • Biomarker Discovery and Validation
  • Cytokine Biology
  • Translational Clinical Research

Research Contributions

Among her recognized scientific contributions is the development of immune-based approaches for evaluating uterine receptivity and implantation potential. Her work has advanced understanding of how cytokine balance and local immune regulation influence successful embryo implantation and pregnancy outcomes.[3]

She is also inventor of patented technologies addressing embryo implantation and oocyte selection. These innovations seek to improve clinical decision-making within IVF and ART programs by introducing objective biological markers into reproductive treatment pathways.[4]

  • Patent PCT WO-2008/009705 involving granulocyte colony-stimulating factor (G-CSF) assessment in follicular fluid.
  • Patent PCT/EP2013/065355 concerning methods for increasing implantation success in assisted reproduction.
  • Leadership of translational fertility research programs connecting laboratory findings to patient care.
  • Contributions to European and international reproductive medicine networks.

Publications

Nathalie Lédée has authored influential studies in reproductive immunology and embryo implantation, including randomized trials on endometrial immune profiling and precision therapy that improved live birth outcomes after embryo transfer.[3] Her work further explored uterine immune profiling in assisted reproductive technology, advancing personalized fertility care.[4] Additional contributions include research on sperm microRNA expression and fertility biomarkers,[5] immune predictors of recurrent miscarriage and therapeutic outcomes,[6] and the role of interleukin-18 in predicting embryo transfer success.[7]

Research Impact

The research record of Nathalie Lédée includes 94 indexed documents, more than 3,407 citations, and an h-index of 33. These indicators reflect sustained scholarly engagement within reproductive medicine and reproductive immunology. Her publications have addressed clinically relevant challenges including implantation failure, recurrent miscarriage, immune biomarkers, and fertility treatment optimization.[1]

Her contributions have been recognized through competitive grants, scientific awards, international fellowships, leadership positions in European research initiatives, and memberships in major professional societies including ESHRE, the American Society of Reproductive Immunology, and European reproductive medicine organizations.[2]

Award Suitability

The nomination of Nathalie Lédée for the Innovative Research Award may be considered on the basis of her long-standing contributions to reproductive medicine, translational immunology, fertility innovation, and clinical leadership. Her work demonstrates a sustained commitment to developing evidence-based approaches that improve reproductive outcomes and expand scientific understanding of embryo implantation biology.[3][4]

Additional factors supporting recognition include internationally patented inventions, leadership in fertility centers, successful integration of biotechnology innovation into healthcare practice, and publication of influential research addressing major challenges in assisted reproduction.[4][5]

Conclusion

Nathalie Lédée has established a distinguished career at the intersection of clinical reproductive medicine, reproductive immunology, and translational biomedical innovation. Through academic research, leadership of fertility programs, biotechnology entrepreneurship, and development of novel diagnostic and therapeutic strategies, she has contributed to advancements in understanding and improving human reproduction. Her body of work represents a notable example of translational science applied to reproductive healthcare.[1][3]

References

  1. Elsevier. (n.d.). Scopus author details: Nathalie Lédée, Author ID 6603321197. Scopus. https://www.scopus.com/authid/detail.uri?authorId=6603321197
  2. ORCID. (n.d.). Nathalie Lédée – ORCID Research Profile. https://orcid.org/0000-0002-3166-2643
  3. Lédée, N., Petitbarat, M., Dray, G., Chevrier, L., Kazhalawi, A., Rahmati, M., et al. (2025). Endometrial immune profiling and precision therapy increase live birth rate after embryo transfer: a randomised controlled trial. Frontiers in Immunology. DOI: https://doi.org/10.3389/fimmu.2025.1523871
  4. Lédée, N., Petitbarat, M., Prat-Ellenberg, L., Dray, G., Vaucoret, V., Kazhalawi, A., et al. (2023). The Next Frontier in ART: Harnessing the Uterine Immune Profile for Improved Performance. International Journal of Molecular Sciences. https://www.mdpi.com/1422-0067/24/14/11322
  5. Cassuto, N.G., Lédée, N., Boitrelle, F., Mouik, H., Larue, L., Keromnes, G., et al. (2025). Genome-Wide microRNA Expression Profiling in Human Spermatozoa and Its Relation to Sperm Quality. Genes. https://www.mdpi.com/2073-4425/16/1/53
  6. Kolanska, K., Lédée, N., Dabi, Y., Dechartres, A., et al. (2021). Unexplained recurrent miscarriages: predictive value of immune biomarkers and immunomodulatory therapies for live birth. American Journal of Reproductive Immunology. https://onlinelibrary.wiley.com/doi/abs/10.1111/aji.13425
  7. Ledee-Bataille, N., Olivennes, F., Kadoch, J., Dubanchet, S., Frydman, N., Chaouat, G., & Frydman, R. Detectable levels of interleukin-18 in uterine luminal secretions at oocyte retrieval predict failure of the embryo transfer. Human Reproduction. DOI: https://doi.org/10.1093/humrep/deh356

Saksham Kohli | Health Professions | Best Researcher Award

Published on by Top Teachers

Best Researcher Award

Saksham Kohli
Cook County Health

Saksham Kohli
Affiliation Cook County Health
Country United States
Scopus ID 59495632900
Documents 52
Citations 4
Subject Area Health Professions
Event Top Teachers Awards
ORCID 0000-0001-6983-1804

The Best Researcher Award recognition highlights the scholarly activities and emerging research contributions of Saksham Kohli at Cook County Health. Working within the field of Health Professions, Saksham Kohli has contributed to studies involving gastroenterology, hepatology, nephrology, and healthcare outcomes research. Recent publications demonstrate engagement with evidence-based clinical investigations addressing inpatient outcomes, quality improvement methodologies, readmission patterns, and patient survival analyses.[1] Through interdisciplinary research and participation in contemporary clinical studies, Saksham Kohli has supported the advancement of knowledge relevant to healthcare quality, patient management, and population-level medical outcomes.[2]

Abstract

This article presents an academic overview of Saksham Kohli and the research profile associated with recognition under the Best Researcher Award category. The researcher’s recent scholarly output focuses on clinical outcomes, gastrointestinal diseases, healthcare quality assessment, and patient-centered investigations. Published studies have addressed metabolic dysfunction-associated liver disease, endoscopy performance evaluation, alcoholic hepatitis readmissions, and survival considerations among elderly dialysis patients.[2]

Keywords

Health Professions, Gastroenterology, Clinical Outcomes Research, Healthcare Quality Improvement, Hepatology, Readmission Studies, Evidence-Based Medicine.

Introduction

Healthcare research plays a significant role in improving clinical practice, patient outcomes, and healthcare system efficiency. Researchers working across medical specialties contribute to evidence generation that supports informed decision-making and policy development. Saksham Kohli’s published work reflects participation in studies examining disease burden, treatment outcomes, healthcare utilization, and quality improvement initiatives within contemporary clinical settings.[3]

Research Profile

Affiliated with Cook County Health in the United States, Saksham Kohli has developed a research profile centered on applied clinical investigations. Indexed under Scopus Author ID 59495632900, the researcher has contributed to publications spanning gastroenterology, hepatology, nephrology, and healthcare analytics. These studies demonstrate engagement with real-world healthcare datasets and outcome-oriented medical research.[1]

Research Contributions

The research contributions of Saksham Kohli include analyses of metabolic-dysfunction-associated steatotic liver disease and its impact on inpatient outcomes, assessments of endoscope tip angulation performance, nationwide evaluations of alcoholic hepatitis readmissions, and investigations involving elderly dialysis populations.[2] These studies contribute to clinical understanding by examining patient outcomes, healthcare quality metrics, and disease management strategies using quantitative methodologies.[4]

Publications

  • Impact of Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD) and Steatohepatitis (MASH) on Clostridioides difficile Inpatient Outcomes.
  • Quantitative Assessment of Endoscope Tip Angulation Performance in New Endoscopes.
  • Trends, Predictors, and Outcomes of 30- and 90-Day Readmissions Following Alcoholic Hepatitis.
  • Octogenarians on Dialysis; Navigating Survival Amidst Struggles.

Research Impact

The available publication record demonstrates contributions to clinically relevant topics affecting patient care and healthcare delivery. Research addressing liver disease outcomes, readmission risk factors, endoscopic performance, and nephrology-related survival outcomes provides useful evidence for healthcare professionals and researchers seeking to improve treatment effectiveness and quality standards.[5]

Award Suitability

Saksham Kohli’s profile aligns with the objectives of the Best Researcher Award through demonstrated scholarly engagement, publication activity, and contributions to healthcare research. The combination of outcome-based studies, quality improvement initiatives, and multidisciplinary clinical investigations reflects an active commitment to advancing medical knowledge and evidence-based practice.[1]

Conclusion

Saksham Kohli has contributed to a growing body of healthcare research through studies addressing important clinical and quality-of-care challenges. The published work demonstrates involvement in contemporary medical investigations and supports the dissemination of evidence relevant to patient outcomes, healthcare systems, and disease management. These accomplishments provide a foundation for recognition within academic and professional research communities.

References

  1. Elsevier. (n.d.). Scopus author details: Saksham Kohli, Author ID 59495632900. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=59495632900
  2. Kohli, S. et al. (2026). Impact of MASLD and MASH on Clostridioides difficile Inpatient Outcomes.
    https://doi.org/10.3390/gastroent17020038
  3. Kohli, S. et al. (2026). Quantitative Assessment of Endoscope Tip Angulation Performance in New Endoscopes.
    https://doi.org/10.1055/a-2877-9452
  4. Kohli, S. et al. (2026). Trends, Predictors, and Outcomes of 30- and 90-Day Readmissions Following Alcoholic Hepatitis.
    https://doi.org/10.3390/gidisord8020027
  5. Kohli, S. et al. (2025). Octogenarians on Dialysis; Navigating Survival Amidst Struggles.
    https://doi.org/10.34172/jnp.2024.21476
  6. Top Teachers Awards. (n.d.). Best Researcher Award Recognition Program.
    topteachers.net

Song Guo Zheng | Medicine and Health Sciences | Best Innovator Award

Published on by Top Teachers

Best Innovator Award

Song Guo Zheng
Shanghai Jiao Tong University, China
Song Guo Zheng
Affiliation Shanghai Jiao Tong University
Country China
Scopus ID 7403146499
Documents 262
Citations 16,675
h-index 75
Subject Area Medicine and Health Sciences
Event Top Teachers Awards
ORCID 0000-0002-5611-4774
Google Scholar 37kvQ18AAAAJ

Song Guo Zheng is a physician-scientist and immunologist whose academic career has spanned molecular immunology, rheumatology, autoimmunity, cell therapy, and translational medicine. His research has contributed to the understanding of regulatory T cells, immune tolerance, autoimmune disease mechanisms, and therapeutic immunomodulation. He currently serves as Chair Professor of Medicine and Dean of the School of Cell and Gene Therapy at Shanghai Jiao Tong University School of Medicine while maintaining extensive leadership roles in international scientific organizations and scholarly publishing.[1]

Abstract

This article evaluates the academic achievements, scientific leadership, educational service, and innovation record of Song Guo Zheng in relation to the Best Innovator Award. His work integrates fundamental immunology with translational medicine, resulting in influential publications, patents, edited books, international collaborations, and leadership positions across major scientific societies. The breadth of his contributions demonstrates sustained impact on biomedical research and clinical immunology.[1]

Keywords

Rheumatology, Immunology, Autoimmunity, T Regulatory Cells, Cell Therapy, GMSC, Tumor Immunity.

Introduction

Over several decades, Song Guo Zheng has established an interdisciplinary research program focused on immune regulation, autoimmune disease pathogenesis, regenerative medicine, and therapeutic cell engineering. His academic development includes medical training in China, doctoral education in France, and faculty appointments at major institutions in the United States and China. His scientific output has contributed to both theoretical and applied aspects of immunological science.[1]

Research Profile

Song Guo Zheng earned an M.D. from Anhui Medical University and later completed a Ph.D. in Molecular Immunology at the University of Orleans, France. His academic appointments have included leadership roles at the University of Southern California, Penn State University, Ohio State University, and Shanghai Jiao Tong University. He has also served as editor, associate editor, and editorial board member for numerous high-impact journals while participating in major international grant-review panels and scientific committees.[1]

Research Contributions

  • Advanced understanding of regulatory T-cell biology and immune tolerance mechanisms.[2]
  • Developed strategies for immune modulation relevant to autoimmune disorders and inflammatory diseases.[3]
  • Contributed to translational research in cell therapy, tumor immunity, and regenerative medicine.
  • Secured multiple granted patents involving regulatory T cells, exosome applications, and immunotherapeutic technologies.[1]
  • Edited scientific books and chapters that support education and dissemination of immunological knowledge.

Publications

Representative publications include influential studies on regulatory T-cell induction, immune tolerance, vitamin-mediated immune regulation, and chronic disease immunobiology. These works have become widely cited within immunology and rheumatology literature.[2][3][4][5][6]

Research Impact

According to the provided scholarly metrics, the researcher has produced 262 indexed documents, accumulated more than 16,675+ citations, and achieved an h-index of 75. These indicators reflect substantial scholarly visibility and influence within biomedical sciences. His leadership in international societies, conference organization, editorial service, and research mentoring further extends the impact of his work beyond publication metrics alone.[1]

Award Suitability

The Best Innovator Award recognizes individuals who demonstrate sustained innovation, measurable research impact, educational leadership, and translational achievement. Song Guo Zheng’s portfolio includes pioneering immunological discoveries, numerous patents, extensive publication activity, scientific leadership, international recognition, and contributions to medical education. These accomplishments collectively support strong consideration for recognition within innovation-focused academic award programs.[1]

Conclusion

Song Guo Zheng has developed a distinguished career characterized by innovation in immunology, leadership in academic medicine, and contributions to translational biomedical research. His scientific achievements, educational service, publication record, patents, and international professional engagement provide a substantial foundation for recognition under the Best Innovator Award framework.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Song Guo Zheng, Author ID 7403146499. Scopus. https://www.scopus.com/authid/detail.uri?authorId=7403146499
  2. Zheng SG, Wang JH, Gray JD, Soucier H, Horwitz DA. Natural and Induced CD4+CD25+ Cells Educate CD4+CD25− Cells to Develop Suppressive Activity. The Journal of Immunology. https://doi.org/10.4049/jimmunol.172.9.5213
  3. Huang Z, Liu Y, Qi G, Brand D, Zheng SG. Role of Vitamin A in the Immune System. Journal of Clinical Medicine. https://doi.org/10.3390/jcm7090258
  4. Zheng SG, Wang J, Wang P, Gray JD, Horwitz DA. IL-2 Is Essential for TGF-β to Convert Naive CD4+CD25− Cells. The Journal of Immunology. https://doi.org/10.4049/jimmunol.178.4.2018
  5. Zheng SG, Gray JD, Ohtsuka K, Yamagiwa S, Horwitz DA. Generation Ex Vivo of TGF-β-Producing Regulatory T Cells. The Journal of Immunology. https://doi.org/10.4049/jimmunol.169.8.4183
  6. Wang H, Chen W, Li D, Yin X, Zhang X, Olsen N, Zheng SG. Vitamin D and Chronic Diseases. Aging and Disease. https://pmc.ncbi.nlm.nih.gov/articles/PMC5440113/

Ömer Yavuz | Medicine and Health Sciences | Excellence in Research Award

Published on by Top Teachers

Excellence in Research Award

Ömer Yavuz
Başakşehir Çam and Sakura City Hospital, Turkey
Ömer Yavuz
Affiliation Başakşehir Çam and Sakura City Hospital
Country Turkey
Scopus ID 56712503200
Documents 11
Citations 44
h-index 4
Subject Area Medicine and Health Sciences
Event Top Teachers Awards

Ömer Yavuz is a thoracic surgery specialist affiliated with Başakşehir Çam and Sakura City Hospital. He has contributed significantly to thoracic surgery research through clinical investigations, minimally invasive surgical innovations, oncological studies, and multidisciplinary collaborations.[1] His academic profile reflects active participation in peer-reviewed publications, international scientific congresses, educational activities, and collaborative healthcare research initiatives within thoracic and pulmonary medicine. The Excellence in Research Award recognizes his distinguished scholarly achievement, sustained scientific contribution, and professional advancement in the field of medicine and health sciences.[2]

Abstract

Ömer Yavuz is a Turkish thoracic surgery specialist whose academic activities encompass clinical thoracic surgery, pulmonary oncology, minimally invasive surgical procedures, robotic thoracic surgery, and perioperative patient management. His scholarly contributions include peer-reviewed journal publications, conference presentations, collaborative multicenter studies, and educational involvement in thoracic surgery seminars.[3] His research portfolio demonstrates continuing engagement with contemporary surgical techniques and evidence-based clinical practice, particularly in lung cancer surgery, thoracic oncology, port catheter applications, and minimally invasive approaches.[4]

Keywords

Thoracic Surgery, Lung Cancer, Robotic Surgery, Pulmonary Oncology, Minimally Invasive Surgery, Thoracic Oncology, Video-Assisted Thoracoscopic Surgery, Surgical Research, Medical Education, Clinical Research.

Introduction

Thoracic surgery remains an essential subspecialty within medicine, requiring the integration of surgical precision, oncological knowledge, and multidisciplinary clinical coordination. Research in this field contributes to the advancement of minimally invasive interventions, perioperative management, and improved long-term patient outcomes. Within this context, Ömer Yavuz has participated in clinical and academic activities addressing thoracic surgical practice, lung cancer management, robotic-assisted procedures, and rare thoracic disorders.[5]

His professional training includes medical education at Gülhane Military Medical Faculty and specialization in thoracic surgery at Gülhane Military Medical Academy Haydarpaşa Training Hospital. Subsequent clinical appointments at Muş State Hospital, Koç University Hospital, and Başakşehir Çam and Sakura City Hospital contributed to the development of his clinical and academic profile.[6]

Research Profile

The research profile of Ömer Yavuz reflects interdisciplinary collaboration across thoracic surgery, oncology, pathology, and minimally invasive surgical technologies. His publications include clinical analyses, surgical case reports, retrospective investigations, translational research studies, and conference proceedings focused on thoracic diseases and operative outcomes.[7]

Research topics addressed in his work include pectus excavatum surgery, pleurodesis techniques, thoracic oncology, spread through air spaces in lung adenocarcinoma, immune profiling after minimally invasive lobectomy, robotic thoracic surgery, port catheter complications, and bibliometric analyses of surgical literature.[8]

In addition to publication activities, he has participated in national and international scientific congresses, including presentations associated with the World Conference on Lung Cancer, the European Society of Thoracic Surgeons, and Turkish thoracic surgery congresses.[9]

Research Contributions

Ömer Yavuz has contributed to research evaluating minimally invasive surgical procedures and thoracic oncological management. His collaborative study on immune profiling after minimally invasive lobectomy examined postoperative immunological responses following thoracic surgical intervention.[10]

Additional research contributions include investigations into thoracic surgical outcomes during the COVID-19 pandemic, demonstrating the feasibility of elective cancer surgery during periods of healthcare system restriction.[11] Other studies addressed prognostic indicators in lung adenocarcinoma, including spread through air spaces identified through PET/CT imaging modalities.[12]

His more recent research activities involve robotic-assisted thoracic surgery, landmark-based port catheter placement techniques, thoracic outlet syndrome procedures, and perioperative management strategies in low-resource surgical settings.[13] Several accepted publications scheduled for 2026 further demonstrate ongoing academic engagement in thoracic surgical innovation and healthcare research productivity.[14]

  • Research in minimally invasive thoracic surgery and robotic-assisted procedures.
  • Clinical investigations in lung cancer surgery and thoracic oncology.
  • Studies involving perioperative outcomes and surgical feasibility during the COVID-19 pandemic.
  • Development of port catheter placement approaches in resource-limited clinical settings.
  • Participation in multidisciplinary and international thoracic surgery collaborations.

Publications

Ömer Yavuz has contributed to thoracic surgery research through publications focused on minimally invasive surgery, thoracic oncology, robotic-assisted procedures, perioperative management, and pulmonary diseases. His scholarly work includes clinical investigations on lung adenocarcinoma, immune profiling after lobectomy, pleurodesis techniques, hyperhidrosis surgery outcomes, and port catheter complications. He has also participated in multidisciplinary and international collaborative studies published in peer-reviewed medical journals, including research related to COVID-19 surgical management and malignant pleural mesothelioma. These publications demonstrate sustained engagement with evidence-based thoracic surgery, innovative surgical methodologies, and contemporary clinical challenges within medicine and health sciences.

Research Impact

The academic contributions of Ömer Yavuz have supported ongoing discussions related to thoracic surgical techniques, perioperative care, robotic-assisted interventions, and oncological thoracic procedures. His Scopus-indexed publication record demonstrates measurable citation activity and participation in collaborative scientific research.[15]

His involvement in educational seminars and professional associations, including the Turkish Thoracic Society, Turkish Society of Thoracic Surgery, and European Society of Thoracic Surgeons, further reflects sustained engagement with academic medicine and surgical education.[16]

  • Peer-reviewed publications indexed in international academic databases.
  • Conference presentations at national and international thoracic surgery congresses.
  • Research participation in EU Framework Program and TÜBİTAK-supported scientific projects.
  • Ongoing publication activity in robotic thoracic surgery and surgical innovation.
  • Academic teaching contributions within thoracic surgery clinical seminars.

Award Suitability

The scholarly record of Ömer Yavuz demonstrates alignment with the objectives of the Excellence in Research Award presented through the Top Teachers Awards platform. His contributions to thoracic surgery research, publication activity in peer-reviewed journals, participation in international congresses, and involvement in educational and collaborative medical initiatives collectively support recognition for academic and professional achievement.[17]

Particular areas of distinction include minimally invasive thoracic surgery, robotic-assisted surgical techniques, thoracic oncology research, and clinical studies concerning perioperative outcomes and surgical methodologies in varying healthcare settings.[18]

Conclusion

Ömer Yavuz has established an academic and clinical profile characterized by ongoing participation in thoracic surgery research, scientific collaboration, and surgical education. His publication history, conference involvement, and clinical specialization reflect continued engagement with evidence-based thoracic surgical practice and medical research development. The breadth of his scholarly contributions within medicine and health sciences provides a substantial basis for recognition through the Excellence in Research Award.[19]

References

    1. Elsevier. (n.d.). Scopus author details: Ömer Yavuz, Author ID 56712503200. Scopus. https://www.scopus.com/authid/detail.uri?authorId=56712503200
    2. Başakşehir Çam and Sakura City Hospital. (n.d.). Thoracic surgery and clinical research activities.
    3. Yıldızhan, A., Candaş, F. H., Yavuz, Ö., et al. (2015). Experiences with the Nuss Procedure in Young Adult Patients with Pectus Excavatum.DOI: https://doi.org/10.5606/tgkdc.dergisi.2015.10497
    4. Erus, S., Öztürk, A. B., Albayrak, Ö., et al. (2021). Immune Profiling After Minimally Invasive Lobectomy. DOI: https://doi.org/10.1093/icvts/ivaa296
    5. Marazioti, A., et al. (2021). KRAS Signaling in Malignant Pleural Mesothelioma. DOI: https://doi.org/10.15252/emmm.202013631
    6. Curriculum Vitae of Ömer Yavuz. (2026). Professional experience and academic background.
    7. Süer, H., et al. (2023). Combination of CEACAM5, EpCAM and CK19 Gene Expressions in Mediastinal Lymph Node Micrometastasis. DOI: https://doi.org/10.1186/s13019-023-02297-z
    8. Yavuz, Ö., İşcan, M. (2025). Port Catheter Thickness and Its Correlation with Complications – Exploring the Millimeter Threshold. DOI: https://doi.org/10.1186/s13019-025-03817-9
    9. European Society of Thoracic Surgeons. (2022). Conference proceedings and poster presentations.
    10. Interactive CardioVascular and Thoracic Surgery. (2021). Immune profiling after minimally invasive lobectomy. DOI: https://doi.org/10.1093/icvts/ivaa296
    11. Kulle, C. B., et al. (2021). Is Elective Cancer Surgery Feasible During the Lock-Down Period of the COVID-19 Pandemic? DOI: https://doi.org/10.1002/jso.26436
    12. Falay, O., et al. (2021). Prediction of Spread Through Air Spaces with Preoperative 18F-FDG PET/CT in Primary Lung Adenocarcinoma. DOI: https://doi.org/10.1097/MNM.0000000000001414
    13. İşcan, M., Yavuz, Ö. (2026). Uniportal Robotic-Assisted Thoracic Surgery for Anatomical Lung Resections. DOI: https://doi.org/10.20452/wiitm.2026.18021
    14. Current Thoracic Surgery. (2026). Accepted publications in thoracic surgery and bibliometric analysis.
    15. Scopus Database Metrics. (n.d.). Author citation indicators and publication statistics.
    16. Turkish Thoracic Society; Turkish Society of Thoracic Surgery; European Society of Thoracic Surgeons. (n.d.). Professional membership records.
    17. Top Teachers Awards. (n.d.). Excellence in Research Award recognition framework. https://topteachers.net/
    18. CTSNet. (2024–2025). Robotic thoracic surgery and port catheter publications.
    19. Academic Curriculum Documentation. (2026). Teaching activities, conference participation, and scholarly output.

Lowane Mygirl-Pearl | Public Health | Women Researcher Award

Published on by Top Teachers

Dr. Lowane Mygirl-Pearl | Public Health | Women Researcher Award

Sefako Makgatho Health Science University | South Africa

Dr. Mygirl Pearl Lowane is a Senior Lecturer in Public Health at Sefako Makgatho Health Sciences University, specializing in HIV, STI, TB, sexual and reproductive health, and epidemiology. She holds a PhD in Public Health and has extensive experience as a Clinical Nurse Practitioner and public health coordinator. Dr. Lowane has authored over 20 peer-reviewed publications, with 132 citations and an h-index of 6, contributing significantly to research on HIV/TB management, mental health, and health systems strengthening. She actively collaborates on multidisciplinary and international studies and has supervised numerous postgraduate students to completion. Her work emphasizes community-based interventions and policy-relevant research, aiming to improve healthcare delivery and outcomes in underserved populations across South Africa and beyond.

Citation Metrics (Scopus)

75
60
40
20

Citations
71

h-index
4

Documents
21

Citations

h-index

Documents

Featured Publications

E Lekalakala-Mokgele, MP Lowane, NM Mogale (2023).
Knowledge, perceptions and attitudes of eHealth and health technology among nursing students from Gauteng Province, South Africa
Healthcare | Journal Article · 2023 · 📊 Citations: 16

MP Lowane, RT Lebese (2022).
Missing appointments by patients on antiretroviral therapy: Professional nurses’ perspective
Curationis | Journal Article · 2022 · 📊 Citations: 15

MP Lowane, RT Lebese (2022).
Why adult patients on antiretroviral therapy miss clinical appointments in rural villages of Limpopo Province, South Africa: An exploratory study. Health SA Gesondheid | Journal Article · 2022 · 📊 Citations: 13

S Acheampong, MP Lowane, L Fernandes (2023).
Experiences of migrant mothers attending vaccination services at primary healthcare facilities
Health SA Gesondheid | Journal Article · 2023 · 📊 Citations: 7

Mohammad Uddin | Medicine and Health Sciences | Research Excellence Award

Published on by Top Teachers

Dr. Mohammad Uddin | Medicine and Health Sciences | Research Excellence Award

Hamamatsu University School of Medicine | Bangladesh

Dr. Mohammad Khaja Mafij Uddin is an Associate Scientist in the Infectious Diseases Division at icddr,b, with over 15 years of expertise in mycobacteriology and tuberculosis (TB) diagnostics. His work integrates molecular, microbiological, and immunological approaches to advance TB detection, drug resistance analysis, and biomarker discovery. He has led and contributed to multiple internationally funded projects, including collaborations with organizations in France, Korea, and the USA, focusing on innovative diagnostics such as targeted next-generation sequencing and non-respiratory TB detection. Dr. Uddin has authored several peer-reviewed publications in high-impact journals, contributing significantly to understanding TB transmission dynamics and extrapulmonary TB. He has mentored graduate students and strengthened laboratory capacity, with his research directly supporting improved TB diagnosis and public health outcomes in high-burden settings.

Citation Metrics (Scopus)

94
75
50
25
0

Citations
94

h-index
4

Documents
5

Citations

h-index

Documents

Featured Publications

Sebiha Demir | Health Sciences | Best Researcher Award

Published on by Top Teachers

Ms. Sebiha Demir | Health Sciences | Best Researcher Award

University Hospital Bonn | Germany

Ms. Sebiha Demir is a dedicated medical researcher specializing in neonatology, neonatal neuroprotection, and perinatal brain injury. Her research focuses on improving clinical outcomes for asphyxiated newborns through evidence-based innovations in therapeutic hypothermia and neurophysiological monitoring. She integrates advanced diagnostic tools such as amplitude-integrated electroencephalography (aEEG) and biochemical profiling to identify early predictors of hypoxic-ischemic encephalopathy (HIE), advancing precision medicine in neonatal intensive care. Her notable publication, “Abnormal Amplitude‐Integrated Electroencephalography and Acidosis as Key Criteria Initiating Therapeutic Hypothermia in Asphyxiated Newborns – Data From the German Hypothermia Registry” (Acta Paediatrica, 2025), demonstrates her significant contribution to establishing objective criteria for initiating life-saving interventions in high-risk neonates. Through collaborative research with multidisciplinary teams across Europe, Dr. Demir has enriched neonatal care protocols and contributed to shaping guidelines for early neurological assessment and treatment strategies. Her internationally recognized publications reflect a strong academic impact and translational value in pediatric and clinical neuroscience. With over 380 citations, an h-index of 10 on Scopus, and 12 on Google Scholar, her scholarly influence and commitment to impactful research are evident. As a forward-thinking clinician–scientist, she continues to advance neonatal research by integrating data-driven insights with compassionate care. Dr. Demir’s excellence, innovation, and dedication to improving neonatal health outcomes position her as a leading figure in her field and a deserving recipient of the Best Researcher Award, honoring her outstanding contributions to advancing neonatal medicine and inspiring future generations of medical scientists.

Publication Profile

Orcid

Featured Publications

Demir, S., Groteklaes, A., Dresbach, T., Müller, A., & Sabir, H. (2025, October 29). Abnormal amplitude-integrated electroencephalography and acidosis as key criteria initiating therapeutic hypothermia in asphyxiated newborns – Data from the German Hypothermia Registry. Acta Paediatrica.

Clareci Cardoso | Public Health | Excellence in Research

Published on by Top Teachers

Prof. Clareci Cardoso | Public Health | Excellence in Research

Associate Professor at Federal University of São João del-Rei, Brazil

Prof. Clareci Silva Cardoso is a distinguished researcher and educator in the field of Public Health, with a strong background in Epidemiology and Mental Health. Born on November 15, 1970, in São Sebastião do Oeste, Brazil, she has dedicated her career to improving healthcare through research, teaching, and policy development. With extensive experience in infectious diseases, chronic conditions, and primary healthcare, she has contributed significantly to scientific advancements. She is actively involved in national and international collaborations, focusing on telehealth, tropical medicine, and quality of life studies. Her leadership roles in academia and public health initiatives make her a key figure in epidemiological research and medical education.

professional profiles📖

ORCID

Scopus Profile

Education 🎓

Prof. Cardoso earned her Ph.D. in Public Health (Epidemiology) from the Federal University of Minas Gerais (UFMG) in 2005, where she studied factors influencing the quality of life in schizophrenia. Prior to that, she completed her Master’s in Public Health (Epidemiology) at UFMG in 2001, focusing on the cross-cultural adaptation of a quality-of-life scale for schizophrenic patients. She also holds a Bachelor’s and Licensure in Psychology from the Federal University of São João del-Rei (UFSJ). Additionally, she specialized in Health Services Administration at the University of Ribeirão Preto (UNAERP). Her postdoctoral research includes studies at UFMG (2024), the University of California, Berkeley (2015), and the University of São Paulo (2015), where she focused on infectious diseases and epidemiology.

work Experience💼

Prof. Cardoso has been an Associate Professor at the Federal University of São João del-Rei (UFSJ) since 2009, where she teaches and conducts research in medicine, public health, and epidemiology. She plays a pivotal role as the Coordinator of the Telehealth Program and represents UFSJ in the Minas Gerais Telehealth Network. She also teaches scientific methodology and psychosocial aspects of medical practice and mentors graduate students in health sciences. Additionally, she has been a researcher and collaborating professor at UFMG since 2004, contributing to the Epidemiology Research Group and the Urban Health Observatory of Belo Horizonte. Her work focuses on urban health, quality of life, and mental health, and she has been actively involved in teaching graduate courses on health event measurement and patient satisfaction.

Research Focus

Prof. Cardoso’s research is centered on Public Health and Epidemiology, with a specific interest in primary healthcare, tropical medicine, telehealth, and chronic diseases. She has made significant contributions to the study of mental health, quality of life, urban health, and infectious diseases. Her work in schizophrenia and psychiatric patient care has led to the development of validated health assessment tools. She is also actively involved in telehealth initiatives, promoting the use of digital solutions to enhance healthcare accessibility. Her research extends to the epidemiology of infectious and parasitic diseases, particularly in vulnerable populations.

Awards & Honors🏆 

Throughout her career, Prof. Cardoso has received multiple recognitions for her contributions to public health research and education. She was awarded a CAPES Scholarship for her master’s, doctoral, and postdoctoral studies, acknowledging her excellence in research. Her work in telehealth and epidemiology has also been recognized by institutions such as the National Institute of Health (NIH) and Brazil’s Ministry of Health. As a Visiting Scholar at the University of Aberdeen in Scotland (2017), she further expanded her research in complex systems and public health. She has also participated in NIH-certified training programs focused on human research ethics and participant protection.

Conclusion✅

Dr. Clareci Silva Cardoso is a highly qualified and impactful researcher with extensive experience in public health, epidemiology, and mental health. Her work in telehealth, quality of life, and infectious diseases contributes significantly to both academic research and real-world healthcare solutions.

She is a strong candidate for the Excellence in Research Award, particularly due to her leadership, interdisciplinary research, and international collaborations. However, further high-impact publications, broader recognition, and large-scale funding initiatives could further enhance her competitiveness for top global research awards.

📚Publications to Noted

Addressing under-registration in Chagas disease mortality: insights from the SaMi-Trop and REDS cohorts

Authors: A.L.D.S. Bierrenbach, Ana Luiza De Souza; C. Di-Lorenzo-Oliveira, Claúdia; N.D. Quintino, Nayara Dornela; A.L. Ribeiro, Antonio L.; E.C. Sabino, Ester Cerdeira

Citations: 0

Year: 2025

Health literacy assessment of individuals with and without Chagas disease: a cross-sectional study

Authors: N.R. Baldoni, Nayara Ragi; N.D. Quintino, Nayara Dornela; A.M. Ferreira, Ariela Mota; E.C. Sabino, Ester Cerdeira; C.S. Cardoso, Clareci Silva

Citations: 0

Year: 2024

Sociodemographic, economic, and academic factors linked with resilience in university students during COVID-19 pandemic: a Brazilian cross-sectional study

Authors: J.E. de Andrade, Jéssica Evelyn; A.L. Meireles, Adriana Lúcia; E.L. Machado, Elaine Leandro; B.C.R. Barbosa, Bruna Carolina Rafael; C.M. Ruas, Cristina Mariano

Citations: 0

Year: 2024

Isotemporal substitution analysis of time between sedentary behavior, and physical activity on sleep quality in younger adults: a multicenter study

Authors: L.A.A. Menezes, Luiz Antônio Alves; B.C.R. Barbosa, Bruna Carolina Rafael; W. de Paula, Waléria; L.S. da Silva, Luciana Saraiva; A.L. Meireles, Adriana Lúcia

Citations: 1

Year: 2024

Sedentary behavior is associated with the mental health of university students during the COVID-19 pandemic, and not practicing physical activity accentuates its adverse effects: cross-sectional study

Authors: B.C.R. Barbosa, Bruna Carolina Rafael; L.A.A. Menezes, Luiz Antônio Alves; W. de Paula, Waléria; L.S. da Silva, Luciana Saraiva; A.L. Meireles, Adriana Lúcia

Citations: 3

Year: 2024

Association between positive serology for COVID-19 and Chagas cardiomyopathy progression: The SaMi-Trop project

Authors: A.M. Ferreira, Ariela Mota; L.C.D. Oliveira-da Silva, Lea Campos De; C.S. Cardoso, Clareci Silva; E.C. Sabino, Ester Cerdeira; A.L.P. Ribeiro, Antonio Luiz Pinho

Citations: 0

Year: 2024

Combination of Tele-Cardiology Tools for Cardiovascular Risk Stratification in Primary Care: Data from the PROVAR+ Study

Authors: L.L. Fraga, Lucas Leal; B.R. Nascimento, Bruno Ramos; B.C. Haiashi, Beatriz Costa; A.L.P. Ribeiro, Antonio Luiz Pinho; C.S. Cardoso, Clareci Silva

Citations: 1

Year: 2024

Gastrointestinal Manifestations of Chagas Disease: A Systematic Review with Meta-Analysis

Authors: N.R. Baldoni, Nayara Ragi; L.C.D.O.D. Silva, Lea Campos De Oliveira Da; A.C.O. Gonçalves, Ana Carolina Oliveira; E.C. Sabino, Ester Cerdeira; C.S. Cardoso, Clareci Silva

Citations: 4

Year: 2024

 

 

Feleke Doyore Agide | Health education | Best Researcher Award

Published on by Top Teachers